FDA Inspection
Pittsburgh Cryobank Inc.Pittsburgh Cryobank Inc. – FDA Inspection, Apr 6, 2017
Record Details
This FDA Inspection record concerns Pittsburgh Cryobank Inc., with an inspection on April 6, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 3cfd44bf-1122-4226-ab9c-72479ab5c08d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012216
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.47(a)Procedures for all other requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pittsburgh Cryobank Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 5, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 17, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 18, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 14, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 22, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Pittsburgh Cryobank Inc.
- FDA Inspection 1181396 - 2022-10-05
- FDA Inspection 1108201 - 2019-09-17
- FDA Inspection 914461 - 2015-02-18
- FDA Inspection 822183 - 2013-03-14
- FDA Inspection 646373 - 2010-02-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.